InvestorsHub Logo
Followers 13
Posts 109
Boards Moderated 0
Alias Born 11/16/2019

Re: GinGinGin post# 39958

Thursday, 07/08/2021 3:31:53 PM

Thursday, July 08, 2021 3:31:53 PM

Post# of 43813
I posted this on ST, but will repost here.

So that anyone isn’t fooled by some of the talk on Twitter that some CVM’s patents will be expiring soon…to be clear…the patents are not worth much. Patents only offer limited protection for the holder, but it doesn't matter for CVM.

Multikine is not a drug and therefore it doesn’t need this type of intellectual protection. It is a complex biologic which makes it nearly impossible to duplicate. In fact, if someone claimed they did duplicate Multikine, FDA would require them to go through a P3 trial.

https://frugalnorwegian.com/drugs-vs-biologics-what-is-the-difference/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News